| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |